MedTrace Logo

Symptom Based Treatment of Neuropathic Pain

NCT02180880 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2014-08-20

No results posted yet for this study

Summary

1\. Neuropathic pain in spinal cord injured patients

1. Inclusion criteria

* pain intensity, visual analogue scale \> 3
* a LANSS (Leeds assessment of neuropathic symptoms and signs) score of 12 and above
* aged ≥20
2. Method

* Stop pain medications
* Test oxcarbazepine (150mg twice daily) and pregabalin (150mg twice daily)
* Check pain intensity (VAS score) with Baron's classification

Conditions

  • Neuralgia
  • Spinal Cord Injury

Interventions

DRUG

Pregabalin and Oxcarbazepine

Subjects will take pregabalin for the duration of 2 weeks. The dosage will be increased from 75 mg twice to 150 mg twice a day. Subjects will stop pregabalin for 1 week and take oxcarbazepine 150mg twice.

Sponsors & Collaborators

  • Ju Seok Ryu

    lead OTHER

Principal Investigators

  • Ju Seok Ryu, MD · CHA University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180880 on ClinicalTrials.gov